0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Research Grade Antibodies Market Research Report 2024
Published Date: June 2024
|
Report Code: QYRE-Auto-9Y12712
Home | Market Reports | Science| Biological Sciences
Global Research Grade Antibodies Market Research Report 2022
BUY CHAPTERS

Global Research Grade Antibodies Market Research Report 2024

Code: QYRE-Auto-9Y12712
Report
June 2024
Pages:100
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Research Grade Antibodies Market

An antibody (also known as an immunoglobulin) is a protective protein produced by the immune system in response to the presence of an antigen. It is a Y-shaped molecule composed of two heavy chains and two light chains, which are held together by disulfide bonds. Each tip of its Y-shaped structure contains a paratope that can specifically bind with an epitope on a corresponding antigen. The antibodies can be then used in a multitude of applications, including but not limited to: western blot (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry (IHC), chromatin immunoprecipitation (ChIP), and flow cytometry (FC). As a cornerstone of the body’s immune response, antibodies can provide significant data to support scientists’ research.
The global Research Grade Antibodies market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.
North American market for Research Grade Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
Asia-Pacific market for Research Grade Antibodies is estimated to increase from $ million in 2023 to reach $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The global market for Research Grade Antibodies in Pharmaceutical & Biotechnology Companies is estimated to increase from $ million in 2023 to $ million by 2030, at a CAGR of % during the forecast period of 2024 through 2030.
The major global companies of Research Grade Antibodies include Abcam, Merck, CST, Thermo Fisher, R&D Systems, BD, Biolegend, Proteintech and ABclonal, etc. In 2023, the world's top three vendors accounted for approximately % of the revenue.
This report aims to provide a comprehensive presentation of the global market for Research Grade Antibodies, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Research Grade Antibodies.

Report Scope

The Research Grade Antibodies market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Research Grade Antibodies market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.
For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.
The report will help the Research Grade Antibodies companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.
Market Segmentation

Scope of Research Grade Antibodies Market Report

Report Metric Details
Report Name Research Grade Antibodies Market
Segment by Type
  • Monoclonal Antibodies
  • Polyclonal Antibodies
Segment by Application
  • Pharmaceutical & Biotechnology Companies
  • CRO/CDMO Companies
  • Academic & Research Institutes
  • Others
By Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company Abcam, Merck, CST, Thermo Fisher, R&D Systems, BD, Biolegend, Proteintech, ABclonal, Bio-Rad, Santa Cruz Biotechnology (SCBT), Novus Biologicals, Genetex, Abnova, Abcepta, Aviva Biosciences, MBL, BioXCell, Sino Biological, HuaBio
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
  • Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
  • Chapter 3: Detailed analysis of Research Grade Antibodies companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
  • Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
  • Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
  • Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
  • Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
  • Chapter 12: The main points and conclusions of the report.

FAQ for this report

Who are the main players in the Research Grade Antibodies Market report?

Ans: The main players in the Research Grade Antibodies Market are Abcam, Merck, CST, Thermo Fisher, R&D Systems, BD, Biolegend, Proteintech, ABclonal, Bio-Rad, Santa Cruz Biotechnology (SCBT), Novus Biologicals, Genetex, Abnova, Abcepta, Aviva Biosciences, MBL, BioXCell, Sino Biological, HuaBio

What are the Application segmentation covered in the Research Grade Antibodies Market report?

Ans: The Applications covered in the Research Grade Antibodies Market report are Pharmaceutical & Biotechnology Companies, CRO/CDMO Companies, Academic & Research Institutes, Others

What are the Type segmentation covered in the Research Grade Antibodies Market report?

Ans: The Types covered in the Research Grade Antibodies Market report are Monoclonal Antibodies, Polyclonal Antibodies

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Research Grade Antibodies Market Size Growth Rate by Type: 2019 VS 2023 VS 2030
1.2.2 Monoclonal Antibodies
1.2.3 Polyclonal Antibodies
1.3 Market by Application
1.3.1 Global Research Grade Antibodies Market Growth by Application: 2019 VS 2023 VS 2030
1.3.2 Pharmaceutical & Biotechnology Companies
1.3.3 CRO/CDMO Companies
1.3.4 Academic & Research Institutes
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Research Grade Antibodies Market Perspective (2019-2030)
2.2 Research Grade Antibodies Growth Trends by Region
2.2.1 Global Research Grade Antibodies Market Size by Region: 2019 VS 2023 VS 2030
2.2.2 Research Grade Antibodies Historic Market Size by Region (2019-2024)
2.2.3 Research Grade Antibodies Forecasted Market Size by Region (2025-2030)
2.3 Research Grade Antibodies Market Dynamics
2.3.1 Research Grade Antibodies Industry Trends
2.3.2 Research Grade Antibodies Market Drivers
2.3.3 Research Grade Antibodies Market Challenges
2.3.4 Research Grade Antibodies Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Research Grade Antibodies Players by Revenue
3.1.1 Global Top Research Grade Antibodies Players by Revenue (2019-2024)
3.1.2 Global Research Grade Antibodies Revenue Market Share by Players (2019-2024)
3.2 Global Research Grade Antibodies Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Research Grade Antibodies Revenue
3.4 Global Research Grade Antibodies Market Concentration Ratio
3.4.1 Global Research Grade Antibodies Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Research Grade Antibodies Revenue in 2023
3.5 Research Grade Antibodies Key Players Head office and Area Served
3.6 Key Players Research Grade Antibodies Product Solution and Service
3.7 Date of Enter into Research Grade Antibodies Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Research Grade Antibodies Breakdown Data by Type
4.1 Global Research Grade Antibodies Historic Market Size by Type (2019-2024)
4.2 Global Research Grade Antibodies Forecasted Market Size by Type (2025-2030)
5 Research Grade Antibodies Breakdown Data by Application
5.1 Global Research Grade Antibodies Historic Market Size by Application (2019-2024)
5.2 Global Research Grade Antibodies Forecasted Market Size by Application (2025-2030)
6 North America
6.1 North America Research Grade Antibodies Market Size (2019-2030)
6.2 North America Research Grade Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
6.3 North America Research Grade Antibodies Market Size by Country (2019-2024)
6.4 North America Research Grade Antibodies Market Size by Country (2025-2030)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Research Grade Antibodies Market Size (2019-2030)
7.2 Europe Research Grade Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
7.3 Europe Research Grade Antibodies Market Size by Country (2019-2024)
7.4 Europe Research Grade Antibodies Market Size by Country (2025-2030)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Research Grade Antibodies Market Size (2019-2030)
8.2 Asia-Pacific Research Grade Antibodies Market Growth Rate by Region: 2019 VS 2023 VS 2030
8.3 Asia-Pacific Research Grade Antibodies Market Size by Region (2019-2024)
8.4 Asia-Pacific Research Grade Antibodies Market Size by Region (2025-2030)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Research Grade Antibodies Market Size (2019-2030)
9.2 Latin America Research Grade Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
9.3 Latin America Research Grade Antibodies Market Size by Country (2019-2024)
9.4 Latin America Research Grade Antibodies Market Size by Country (2025-2030)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Research Grade Antibodies Market Size (2019-2030)
10.2 Middle East & Africa Research Grade Antibodies Market Growth Rate by Country: 2019 VS 2023 VS 2030
10.3 Middle East & Africa Research Grade Antibodies Market Size by Country (2019-2024)
10.4 Middle East & Africa Research Grade Antibodies Market Size by Country (2025-2030)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Abcam
11.1.1 Abcam Company Detail
11.1.2 Abcam Business Overview
11.1.3 Abcam Research Grade Antibodies Introduction
11.1.4 Abcam Revenue in Research Grade Antibodies Business (2019-2024)
11.1.5 Abcam Recent Development
11.2 Merck
11.2.1 Merck Company Detail
11.2.2 Merck Business Overview
11.2.3 Merck Research Grade Antibodies Introduction
11.2.4 Merck Revenue in Research Grade Antibodies Business (2019-2024)
11.2.5 Merck Recent Development
11.3 CST
11.3.1 CST Company Detail
11.3.2 CST Business Overview
11.3.3 CST Research Grade Antibodies Introduction
11.3.4 CST Revenue in Research Grade Antibodies Business (2019-2024)
11.3.5 CST Recent Development
11.4 Thermo Fisher
11.4.1 Thermo Fisher Company Detail
11.4.2 Thermo Fisher Business Overview
11.4.3 Thermo Fisher Research Grade Antibodies Introduction
11.4.4 Thermo Fisher Revenue in Research Grade Antibodies Business (2019-2024)
11.4.5 Thermo Fisher Recent Development
11.5 R&D Systems
11.5.1 R&D Systems Company Detail
11.5.2 R&D Systems Business Overview
11.5.3 R&D Systems Research Grade Antibodies Introduction
11.5.4 R&D Systems Revenue in Research Grade Antibodies Business (2019-2024)
11.5.5 R&D Systems Recent Development
11.6 BD
11.6.1 BD Company Detail
11.6.2 BD Business Overview
11.6.3 BD Research Grade Antibodies Introduction
11.6.4 BD Revenue in Research Grade Antibodies Business (2019-2024)
11.6.5 BD Recent Development
11.7 Biolegend
11.7.1 Biolegend Company Detail
11.7.2 Biolegend Business Overview
11.7.3 Biolegend Research Grade Antibodies Introduction
11.7.4 Biolegend Revenue in Research Grade Antibodies Business (2019-2024)
11.7.5 Biolegend Recent Development
11.8 Proteintech
11.8.1 Proteintech Company Detail
11.8.2 Proteintech Business Overview
11.8.3 Proteintech Research Grade Antibodies Introduction
11.8.4 Proteintech Revenue in Research Grade Antibodies Business (2019-2024)
11.8.5 Proteintech Recent Development
11.9 ABclonal
11.9.1 ABclonal Company Detail
11.9.2 ABclonal Business Overview
11.9.3 ABclonal Research Grade Antibodies Introduction
11.9.4 ABclonal Revenue in Research Grade Antibodies Business (2019-2024)
11.9.5 ABclonal Recent Development
11.10 Bio-Rad
11.10.1 Bio-Rad Company Detail
11.10.2 Bio-Rad Business Overview
11.10.3 Bio-Rad Research Grade Antibodies Introduction
11.10.4 Bio-Rad Revenue in Research Grade Antibodies Business (2019-2024)
11.10.5 Bio-Rad Recent Development
11.11 Santa Cruz Biotechnology (SCBT)
11.11.1 Santa Cruz Biotechnology (SCBT) Company Detail
11.11.2 Santa Cruz Biotechnology (SCBT) Business Overview
11.11.3 Santa Cruz Biotechnology (SCBT) Research Grade Antibodies Introduction
11.11.4 Santa Cruz Biotechnology (SCBT) Revenue in Research Grade Antibodies Business (2019-2024)
11.11.5 Santa Cruz Biotechnology (SCBT) Recent Development
11.12 Novus Biologicals
11.12.1 Novus Biologicals Company Detail
11.12.2 Novus Biologicals Business Overview
11.12.3 Novus Biologicals Research Grade Antibodies Introduction
11.12.4 Novus Biologicals Revenue in Research Grade Antibodies Business (2019-2024)
11.12.5 Novus Biologicals Recent Development
11.13 Genetex
11.13.1 Genetex Company Detail
11.13.2 Genetex Business Overview
11.13.3 Genetex Research Grade Antibodies Introduction
11.13.4 Genetex Revenue in Research Grade Antibodies Business (2019-2024)
11.13.5 Genetex Recent Development
11.14 Abnova
11.14.1 Abnova Company Detail
11.14.2 Abnova Business Overview
11.14.3 Abnova Research Grade Antibodies Introduction
11.14.4 Abnova Revenue in Research Grade Antibodies Business (2019-2024)
11.14.5 Abnova Recent Development
11.15 Abcepta
11.15.1 Abcepta Company Detail
11.15.2 Abcepta Business Overview
11.15.3 Abcepta Research Grade Antibodies Introduction
11.15.4 Abcepta Revenue in Research Grade Antibodies Business (2019-2024)
11.15.5 Abcepta Recent Development
11.16 Aviva Biosciences
11.16.1 Aviva Biosciences Company Detail
11.16.2 Aviva Biosciences Business Overview
11.16.3 Aviva Biosciences Research Grade Antibodies Introduction
11.16.4 Aviva Biosciences Revenue in Research Grade Antibodies Business (2019-2024)
11.16.5 Aviva Biosciences Recent Development
11.17 MBL
11.17.1 MBL Company Detail
11.17.2 MBL Business Overview
11.17.3 MBL Research Grade Antibodies Introduction
11.17.4 MBL Revenue in Research Grade Antibodies Business (2019-2024)
11.17.5 MBL Recent Development
11.18 BioXCell
11.18.1 BioXCell Company Detail
11.18.2 BioXCell Business Overview
11.18.3 BioXCell Research Grade Antibodies Introduction
11.18.4 BioXCell Revenue in Research Grade Antibodies Business (2019-2024)
11.18.5 BioXCell Recent Development
11.19 Sino Biological
11.19.1 Sino Biological Company Detail
11.19.2 Sino Biological Business Overview
11.19.3 Sino Biological Research Grade Antibodies Introduction
11.19.4 Sino Biological Revenue in Research Grade Antibodies Business (2019-2024)
11.19.5 Sino Biological Recent Development
11.20 HuaBio
11.20.1 HuaBio Company Detail
11.20.2 HuaBio Business Overview
11.20.3 HuaBio Research Grade Antibodies Introduction
11.20.4 HuaBio Revenue in Research Grade Antibodies Business (2019-2024)
11.20.5 HuaBio Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
List of Tables
    Table 1. Global Research Grade Antibodies Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030
    Table 2. Key Players of Monoclonal Antibodies
    Table 3. Key Players of Polyclonal Antibodies
    Table 4. Global Research Grade Antibodies Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030
    Table 5. Global Research Grade Antibodies Market Size by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 6. Global Research Grade Antibodies Market Size by Region (2019-2024) & (US$ Million)
    Table 7. Global Research Grade Antibodies Market Share by Region (2019-2024)
    Table 8. Global Research Grade Antibodies Forecasted Market Size by Region (2025-2030) & (US$ Million)
    Table 9. Global Research Grade Antibodies Market Share by Region (2025-2030)
    Table 10. Research Grade Antibodies Market Trends
    Table 11. Research Grade Antibodies Market Drivers
    Table 12. Research Grade Antibodies Market Challenges
    Table 13. Research Grade Antibodies Market Restraints
    Table 14. Global Research Grade Antibodies Revenue by Players (2019-2024) & (US$ Million)
    Table 15. Global Research Grade Antibodies Market Share by Players (2019-2024)
    Table 16. Global Top Research Grade Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Research Grade Antibodies as of 2023)
    Table 17. Ranking of Global Top Research Grade Antibodies Companies by Revenue (US$ Million) in 2023
    Table 18. Global 5 Largest Players Market Share by Research Grade Antibodies Revenue (CR5 and HHI) & (2019-2024)
    Table 19. Key Players Headquarters and Area Served
    Table 20. Key Players Research Grade Antibodies Product Solution and Service
    Table 21. Date of Enter into Research Grade Antibodies Market
    Table 22. Mergers & Acquisitions, Expansion Plans
    Table 23. Global Research Grade Antibodies Market Size by Type (2019-2024) & (US$ Million)
    Table 24. Global Research Grade Antibodies Revenue Market Share by Type (2019-2024)
    Table 25. Global Research Grade Antibodies Forecasted Market Size by Type (2025-2030) & (US$ Million)
    Table 26. Global Research Grade Antibodies Revenue Market Share by Type (2025-2030)
    Table 27. Global Research Grade Antibodies Market Size by Application (2019-2024) & (US$ Million)
    Table 28. Global Research Grade Antibodies Revenue Market Share by Application (2019-2024)
    Table 29. Global Research Grade Antibodies Forecasted Market Size by Application (2025-2030) & (US$ Million)
    Table 30. Global Research Grade Antibodies Revenue Market Share by Application (2025-2030)
    Table 31. North America Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 32. North America Research Grade Antibodies Market Size by Country (2019-2024) & (US$ Million)
    Table 33. North America Research Grade Antibodies Market Size by Country (2025-2030) & (US$ Million)
    Table 34. Europe Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 35. Europe Research Grade Antibodies Market Size by Country (2019-2024) & (US$ Million)
    Table 36. Europe Research Grade Antibodies Market Size by Country (2025-2030) & (US$ Million)
    Table 37. Asia-Pacific Research Grade Antibodies Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030
    Table 38. Asia-Pacific Research Grade Antibodies Market Size by Region (2019-2024) & (US$ Million)
    Table 39. Asia-Pacific Research Grade Antibodies Market Size by Region (2025-2030) & (US$ Million)
    Table 40. Latin America Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 41. Latin America Research Grade Antibodies Market Size by Country (2019-2024) & (US$ Million)
    Table 42. Latin America Research Grade Antibodies Market Size by Country (2025-2030) & (US$ Million)
    Table 43. Middle East & Africa Research Grade Antibodies Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030
    Table 44. Middle East & Africa Research Grade Antibodies Market Size by Country (2019-2024) & (US$ Million)
    Table 45. Middle East & Africa Research Grade Antibodies Market Size by Country (2025-2030) & (US$ Million)
    Table 46. Abcam Company Detail
    Table 47. Abcam Business Overview
    Table 48. Abcam Research Grade Antibodies Product
    Table 49. Abcam Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 50. Abcam Recent Development
    Table 51. Merck Company Detail
    Table 52. Merck Business Overview
    Table 53. Merck Research Grade Antibodies Product
    Table 54. Merck Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 55. Merck Recent Development
    Table 56. CST Company Detail
    Table 57. CST Business Overview
    Table 58. CST Research Grade Antibodies Product
    Table 59. CST Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 60. CST Recent Development
    Table 61. Thermo Fisher Company Detail
    Table 62. Thermo Fisher Business Overview
    Table 63. Thermo Fisher Research Grade Antibodies Product
    Table 64. Thermo Fisher Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 65. Thermo Fisher Recent Development
    Table 66. R&D Systems Company Detail
    Table 67. R&D Systems Business Overview
    Table 68. R&D Systems Research Grade Antibodies Product
    Table 69. R&D Systems Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 70. R&D Systems Recent Development
    Table 71. BD Company Detail
    Table 72. BD Business Overview
    Table 73. BD Research Grade Antibodies Product
    Table 74. BD Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 75. BD Recent Development
    Table 76. Biolegend Company Detail
    Table 77. Biolegend Business Overview
    Table 78. Biolegend Research Grade Antibodies Product
    Table 79. Biolegend Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 80. Biolegend Recent Development
    Table 81. Proteintech Company Detail
    Table 82. Proteintech Business Overview
    Table 83. Proteintech Research Grade Antibodies Product
    Table 84. Proteintech Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 85. Proteintech Recent Development
    Table 86. ABclonal Company Detail
    Table 87. ABclonal Business Overview
    Table 88. ABclonal Research Grade Antibodies Product
    Table 89. ABclonal Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 90. ABclonal Recent Development
    Table 91. Bio-Rad Company Detail
    Table 92. Bio-Rad Business Overview
    Table 93. Bio-Rad Research Grade Antibodies Product
    Table 94. Bio-Rad Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 95. Bio-Rad Recent Development
    Table 96. Santa Cruz Biotechnology (SCBT) Company Detail
    Table 97. Santa Cruz Biotechnology (SCBT) Business Overview
    Table 98. Santa Cruz Biotechnology (SCBT) Research Grade Antibodies Product
    Table 99. Santa Cruz Biotechnology (SCBT) Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 100. Santa Cruz Biotechnology (SCBT) Recent Development
    Table 101. Novus Biologicals Company Detail
    Table 102. Novus Biologicals Business Overview
    Table 103. Novus Biologicals Research Grade Antibodies Product
    Table 104. Novus Biologicals Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 105. Novus Biologicals Recent Development
    Table 106. Genetex Company Detail
    Table 107. Genetex Business Overview
    Table 108. Genetex Research Grade Antibodies Product
    Table 109. Genetex Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 110. Genetex Recent Development
    Table 111. Abnova Company Detail
    Table 112. Abnova Business Overview
    Table 113. Abnova Research Grade Antibodies Product
    Table 114. Abnova Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 115. Abnova Recent Development
    Table 116. Abcepta Company Detail
    Table 117. Abcepta Business Overview
    Table 118. Abcepta Research Grade Antibodies Product
    Table 119. Abcepta Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 120. Abcepta Recent Development
    Table 121. Aviva Biosciences Company Detail
    Table 122. Aviva Biosciences Business Overview
    Table 123. Aviva Biosciences Research Grade Antibodies Product
    Table 124. Aviva Biosciences Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 125. Aviva Biosciences Recent Development
    Table 126. MBL Company Detail
    Table 127. MBL Business Overview
    Table 128. MBL Research Grade Antibodies Product
    Table 129. MBL Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 130. MBL Recent Development
    Table 131. BioXCell Company Detail
    Table 132. BioXCell Business Overview
    Table 133. BioXCell Research Grade Antibodies Product
    Table 134. BioXCell Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 135. BioXCell Recent Development
    Table 136. Sino Biological Company Detail
    Table 137. Sino Biological Business Overview
    Table 138. Sino Biological Research Grade Antibodies Product
    Table 139. Sino Biological Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 140. Sino Biological Recent Development
    Table 141. HuaBio Company Detail
    Table 142. HuaBio Business Overview
    Table 143. HuaBio Research Grade Antibodies Product
    Table 144. HuaBio Revenue in Research Grade Antibodies Business (2019-2024) & (US$ Million)
    Table 145. HuaBio Recent Development
    Table 146. Research Programs/Design for This Report
    Table 147. Key Data Information from Secondary Sources
    Table 148. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Research Grade Antibodies Market Size Comparison by Type (2024-2030) & (US$ Million)
    Figure 2. Global Research Grade Antibodies Market Share by Type: 2023 VS 2030
    Figure 3. Monoclonal Antibodies Features
    Figure 4. Polyclonal Antibodies Features
    Figure 5. Global Research Grade Antibodies Market Size Comparison by Application (2024-2030) & (US$ Million)
    Figure 6. Global Research Grade Antibodies Market Share by Application: 2023 VS 2030
    Figure 7. Pharmaceutical & Biotechnology Companies Case Studies
    Figure 8. CRO/CDMO Companies Case Studies
    Figure 9. Academic & Research Institutes Case Studies
    Figure 10. Others Case Studies
    Figure 11. Research Grade Antibodies Report Years Considered
    Figure 12. Global Research Grade Antibodies Market Size (US$ Million), Year-over-Year: 2019-2030
    Figure 13. Global Research Grade Antibodies Market Size, (US$ Million), 2019 VS 2023 VS 2030
    Figure 14. Global Research Grade Antibodies Market Share by Region: 2023 VS 2030
    Figure 15. Global Research Grade Antibodies Market Share by Players in 2023
    Figure 16. Global Top Research Grade Antibodies Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Research Grade Antibodies as of 2023)
    Figure 17. The Top 10 and 5 Players Market Share by Research Grade Antibodies Revenue in 2023
    Figure 18. North America Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 19. North America Research Grade Antibodies Market Share by Country (2019-2030)
    Figure 20. United States Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 21. Canada Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 22. Europe Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 23. Europe Research Grade Antibodies Market Share by Country (2019-2030)
    Figure 24. Germany Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 25. France Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 26. U.K. Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 27. Italy Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 28. Russia Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 29. Nordic Countries Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 30. Asia-Pacific Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 31. Asia-Pacific Research Grade Antibodies Market Share by Region (2019-2030)
    Figure 32. China Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 33. Japan Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 34. South Korea Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 35. Southeast Asia Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 36. India Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 37. Australia Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 38. Latin America Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 39. Latin America Research Grade Antibodies Market Share by Country (2019-2030)
    Figure 40. Mexico Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 41. Brazil Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 42. Middle East & Africa Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 43. Middle East & Africa Research Grade Antibodies Market Share by Country (2019-2030)
    Figure 44. Turkey Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 45. Saudi Arabia Research Grade Antibodies Market Size YoY Growth (2019-2030) & (US$ Million)
    Figure 46. Abcam Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 47. Merck Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 48. CST Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 49. Thermo Fisher Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 50. R&D Systems Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 51. BD Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 52. Biolegend Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 53. Proteintech Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 54. ABclonal Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 55. Bio-Rad Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 56. Santa Cruz Biotechnology (SCBT) Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 57. Novus Biologicals Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 58. Genetex Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 59. Abnova Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 60. Abcepta Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 61. Aviva Biosciences Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 62. MBL Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 63. BioXCell Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 64. Sino Biological Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 65. HuaBio Revenue Growth Rate in Research Grade Antibodies Business (2019-2024)
    Figure 66. Bottom-up and Top-down Approaches for This Report
    Figure 67. Data Triangulation
    Figure 68. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$2900

This license allows only one user to access the PDF.
Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano Dimension